Europe — EMA
Octanate (Human Coagulation Factor Viii)
Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use.
Request sourcing
What is Human Coagulation Factor Viii?
Human Coagulation Factor VIII, the active ingredient in Octanate, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It treats hemophilia A by providing the missing clotting protein in patients with this inherited disorder. GNH USA supplies Octanate as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Octanate as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Coagulation Factor Viii used for?
Octanate is a coagulation factor replacement used in the hemophilia A treatment pathway.
- Hemophilia A (severe): Improves clot formation and reduces bleeding episodes. - Hemophilia A (moderate) : ... ... ... - ... - .... - .... ... ... ... .... ... ...
What are the side effects of Human Coagulation Factor Viii?
The ... .... ...
